about
Presentation of smoking-associated cues does not elicit dopamine release after one-hour smoking abstinence: A [11C]-(+)-PHNO PET studyAn automated method for the extraction of regional data from PET images.Analysis of variance in neuroreceptor ligand imaging studies.Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography studyTranslocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA.Feasibility study of TSPO quantification with [18F]FEPPA using population-based input functionPrefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease.Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO.Mapping human brain fatty acid amide hydrolase activity with PET.Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNOElevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humansConvergent effects of acute stress and glucocorticoid exposure upon MAO-A in humans.Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.Extrastriatal dopaminergic dysfunction in tourette syndrome.Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image-guided neuronavigation.Whole body biodistribution and radiation dosimetry in humans of a new PET ligand, [(18)F]-FEPPA, to image translocator protein (18 kDa).Potentiation of gamma oscillatory activity through repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex.The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics.Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?Serotonin-1A receptors in frontotemporal dementia compared with controls.Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study.The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.Positron emission tomography quantification of [11C]-(+)-PHNO binding in the human brain.Dopamine response to psychosocial stress in humans and its relationship to individual differences in personality traits.Effects of antipsychotics on D3 receptors: a clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO.Voxel level quantification of [11C]CURB, a radioligand for Fatty Acid Amide Hydrolase, using high resolution positron emission tomography.Increased stress-induced dopamine release in psychosis.Elevated fatty acid amide hydrolase in the prefrontal cortex of borderline personality disorder: a [11C]CURB positron emission tomography study
P50
Q28489113-203C0140-FCFB-42F4-9AA5-FB5DC04800E2Q33247822-F608AAE3-C378-4AEB-A5EB-8AAEECA780D3Q33999407-871751A4-84AB-4D2B-9ED3-49C4DCDEC3E1Q34801837-ADCC3DAD-0E0C-4869-B916-5C094EF1A39EQ35800533-2BA9CCA4-5EC8-4A4B-9AE9-30B0272CF3FFQ36008271-F53C7018-425B-4AF5-9E06-7E4746FFD9FFQ36381512-048BD3CD-4D16-447E-BCA4-B5CC34436A0BQ36524516-0A77DBDF-AECA-46B3-A413-05400875B95BQ36610068-6CB97AB1-5CC6-4202-92C4-77727AABF7BFQ36655387-BE9F362E-72A7-412D-998B-570BE36B87DFQ37409577-D6232877-E11D-478F-96E6-544BCEDB7F4CQ37409589-941696DC-9247-43EC-A77D-36A4C52C9830Q39235456-BFAEC2C4-0439-4C94-8EBD-50F43ABE2AF8Q40213723-84FA9E5B-B3EE-4D7A-BC1C-2243232D6A24Q43131989-60D38ECE-1270-4EEE-9577-89F132E28925Q43159461-416F5F77-1213-4C41-B0E8-F791EA7EA05FQ44951340-E05EE6E5-8C4D-498B-AF75-9E0090B5BC8CQ45928217-3E945AAB-E30C-4B67-9D67-C4B26B8F1706Q46051346-C8EC9FB0-12AA-4CB7-9552-E5C478E058BEQ46157390-F9427509-F86A-442A-9658-219D3B7A0C54Q46348738-A5CEC29D-FF04-4512-8F7D-CE6C5F647021Q46919210-F9A96316-EF5B-426B-B1FE-910958C1A477Q48170494-EF2156DA-7B0C-4844-89FC-73562EA710A2Q48218651-CBB984D0-2DC5-4FF1-82F7-08CC29A6B309Q48286844-7C06D1E7-632D-4F33-9AFD-4F7F0001F88AQ48398973-D874A1CB-AA62-4485-922A-9D12EC8EC73DQ48583822-AB0ABE78-13EB-472D-881E-CFA610BE8F38Q49154108-C786B754-F9E2-471D-915C-786FBAACE280Q50000433-7B6182F9-4EC7-4C8D-B374-311564B79714Q50777739-3313C8A3-06A8-4CE4-ADD0-E791AE6D54A4Q96294260-75D27C0F-6B3B-4D15-8ED5-FAC139328DF4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pablo Rusjan
@ast
Pablo Rusjan
@en
Pablo Rusjan
@es
Pablo Rusjan
@nl
Pablo Rusjan
@sl
type
label
Pablo Rusjan
@ast
Pablo Rusjan
@en
Pablo Rusjan
@es
Pablo Rusjan
@nl
Pablo Rusjan
@sl
altLabel
P Rusjan
@en
prefLabel
Pablo Rusjan
@ast
Pablo Rusjan
@en
Pablo Rusjan
@es
Pablo Rusjan
@nl
Pablo Rusjan
@sl
P106
P21
P31
P4012
P496
0000-0003-0075-2918